What is the current Price Target for the Spruce Biosciences Inc stock?

The average Spruce Biosciences Inc target price is $137.19. This is 53.80% higher than the current stock price. The highest price target is 204.88%, the lowest is -88.68%. 4 Analysts have issued a price target Spruce Biosciences Inc 2026 .

How high will the Spruce Biosciences Inc stock rise?

No reliable answer can be given as to how high the Spruce Biosciences Inc stock will rise. The performance of stocks, including the Spruce Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Spruce Biosciences Inc stock today?

The performance of Spruce Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Spruce Biosciences Inc stock fall?

The decline in Spruce Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Spruce Biosciences Inc Forecast, price target & analysts

$93.55

4.88% today

Nasdaq, Dec 03, 05:49 pm CET

ISIN

US85209E1091

Symbol

SPRB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Spruce Biosciences Inc Target price 2025 - Analyst rating & recommendation

Spruce Biosciences Inc Classifications & Recommendation:

Buy

75%

Hold

25%

Spruce Biosciences Inc Price Target

Target Price	$137.19
Price	$89.20
Potential	53.80% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Spruce Biosciences Inc 2026 . The average Spruce Biosciences Inc target price is $137.19. This is 53.80% register free of charge higher than the current stock price. The highest price target is $271.95 204.88% register free of charge , the lowest is $10.10 88.68% register free of charge .
	A rating was issued by 8 analysts: 6 Analysts recommend Spruce Biosciences Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Spruce Biosciences Inc stock has an average upside potential 2026 of 53.80% register free of charge . Most analysts recommend the Spruce Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-96.42	-22.46
	3.29%	76.71%
P/E		negative

4 Analysts have issued a Spruce Biosciences Inc forecast for earnings per share. The average Spruce Biosciences Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-96.42	3.29%
2025	$-22.46 76.71% Unlock
2026	$-11.54 48.62% Unlock
2027	$-10.73 7.02% Unlock

Current	-1.09	91.59%
2025	-3.97 263.92% Unlock
2026	-7.73 94.71% Unlock
2027	-8.31 7.50% Unlock

Spruce Biosciences Inc...

Current Spruce Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citizens	Locked ➜ Locked	Locked	Nov 11 2025
JMP Securities	Locked ➜ Locked	Locked	Oct 28 2025
Leerink Partners	Locked ➜ Locked	Locked	Oct 21 2025
RBC Capital	Locked ➜ Locked	Locked	Apr 16 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 16 2024
Guggenheim	Locked ➜ Locked	Locked	Dec 12 2024
JMP Securities	Locked ➜ Locked	Locked	Dec 11 2024

Analyst Rating	Date
Locked Citizens: Locked ➜ Locked	Nov 11 2025
Locked JMP Securities: Locked ➜ Locked	Oct 28 2025
Locked Leerink Partners: Locked ➜ Locked	Oct 21 2025
Locked RBC Capital: Locked ➜ Locked	Apr 16 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 16 2024
Locked Guggenheim: Locked ➜ Locked	Dec 12 2024
Locked JMP Securities: Locked ➜ Locked	Dec 11 2024

Discover more stocks with a high price target

Netflix 1,196.57%

Coinbase Global, Inc. 54.98%

Rheinmetall 50.60%

Adidas 49.35%

BioNTech SE - ADR 46.99%

NIO ADR 41.95%

BYD 41.35%

Deutsche Telekom 40.84%

TUI 37.77%

Novo Nordisk 37.45%

Adyen 35.80%

Meta Platforms (Facebook) 33.98%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now